Trial | NCT02949960  Report issue

Title

DMT210 Topical Gel in the Treatment of Atopic Dermatitis
DMT210 Topical Gel in the Treatment of Mild to Moderate Atopic Dermatitis

  • Phase

    Phase 2

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Intervention/Treatment

    dmt210 ...

  • Study Participants

    19
The objective of the study is to evaluate the safety and efficacy of DMT210 Gel, 5% compared to vehicle control following 28 days of twice-daily topical application to selected target lesions in male and female patients with mild to moderate atopic dermatitis (AD).
Study Started
Oct 31
2016
Primary Completion
Jul 14
2017
Study Completion
Jul 14
2017
Last Update
Apr 18
2018

Drug DMT210 Topical Gel

DMT210 Topical Aqueous Gel 5% applied twice daily

Drug Vehicle Control

Topical Vehicle Gel applied twice daily

DMT210 Topical Gel Experimental

DMT210 Topical Gel 5% applied to target lesion twice daily

Vehicle Control Placebo Comparator

Topical Gel vehicle applied to target lesion twice daily

Criteria 

Inclusion Criteria:

Male or female 12 years or older
Patient has chronic, stable AD that has been present for at least 3 months with 5-35% (inclusive) BSA (Body Surface Area) of AD involvement
Patient has two analogous, Target Lesions; one lesion within each of the two Treatment Areas
Patient is willing and able to comply with the protocol

Exclusion Criteria:

Patient has used topical therapies for AD within the Treatment Areas 2 weeks before baseline
No Results Posted